Review: Prevalence and severity of corona virus disease 2019 (COVID-19): a systematic review and meta-analysis

Home/Review: Prevalence and severity of corona virus disease 2019 (COVID-19): a systematic review and meta-analysis

Review: Prevalence and severity of corona virus disease 2019 (COVID-19): a systematic review and meta-analysis

Review: Prevalence and severity of corona virus disease 2019 (COVID-19): a systematic review and meta-analysis

This systematic review and meta analysis evaluates the risk factors of COVID-19.

The authors examined 21 clinical and epidemiological studies on confirmed cases of COVID-19 published January 1, 1980 to March 10, 2020. A total of 47,344 (24,419 male and 22,925 female) were included in the meta analysis.

Their main findings include:

  • Cases reported to date suggest that most are older adults
  • There is no difference in susceptibility between males and females
  • Fever is the most common symptom in patients with 2019-nCoV infection
  • The most prevalent comorbidities are hypertension and diabetes which are associated with the rapid development of severe illness
  • cute respiratory distress syndrome and acute cardiac injury may be the main obstacles for patients to treatment recovery
  • The severity and mortality of patients with 2019-nCoV infection is lower than that of Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS), but the prevalence of COVID-19 is much higher than SARS and the MERS
|2020-04-22T16:32:11-04:00April 22nd, 2020|COVID-19 Literature|Comments Off on Review: Prevalence and severity of corona virus disease 2019 (COVID-19): a systematic review and meta-analysis

About the Author: Erika Cheng

Erika Cheng

Get Involved with Indiana CTSI